India Britain Argentina Sweden city Oxford covid-19 vaccine Coronavirus India Britain Argentina Sweden city Oxford

Covishield: How effective is it against novel COVID-19? What we know so far

Reading now: 401
www.livemint.com

COVID-19 vaccine drive via video conferencing at 10.30 am on Saturday.India approved the emergency authorisation of two vaccines against novel coronavirus — Covaxin by Bharat Biotech and Covishield by Serum Institute of India.

Earlier, Britain and Argentina had approved the emergency marker use of coronavirus vaccine developed by the University of Oxford and AstraZeneca.

Serum Institute of India, the world's largest vaccine manufacturer by volume, joined hands with British-Swedish drugmaker to produce 1 billion doses of its COVID-19 vaccine.

The local version of Oxford-AstraZeneca COVID-19 vaccine will be known as Covishield.How does this vaccine work?The 'virus-vectored' vaccine uses a weakened version of a chimpanzee common coldvirus that.

Read more on livemint.com
The website covid-19.rehab is an aggregator of news from open sources. The source is indicated at the beginning and at the end of the announcement. You can send a complaint on the news if you find it unreliable.

Related News

DMCA